Lv5
840 积分 2023-06-12 加入
Development of a Rating Scale for Primary Depressive Illness
2天前
已完结
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
2天前
已完结
A New Standard in Muscle-Invasive Bladder Cancer - The End of the Cisplatin Era?
20天前
已完结
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
20天前
已完结
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trial
23天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
23天前
已完结
Dalpiciclib plus endocrine therapy in women with HR/HER2+− advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial
1个月前
已完结
Ensartinib in Resected ALK-Positive Non–Small-Cell Lung Cancer
1个月前
已完结
Progress toward personalized management of stage II/III triple negative breast cancer
1个月前
已完结
“Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
1个月前
已关闭
皖公网安备34019202002308
